IL6 and acute respiratory distress syndrome: We demonstrated that MSC SLP inhibited the IL-6–p-STAT3 signaling pathway and then activated p63–JAG2 signaling to promote epithelial cell proliferation, inhibit cell apoptosis, reduce inflammatory cell recruitment, and ameliorate ALI.